Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Current Breast Cancer Reports
Erschienen in: Current Breast Cancer Reports 2/2016

13.04.2016 | Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

Role of Breast MRI in Patients with Newly Diagnosed Breast Cancer

verfasst von: Marissa L. Albert, Yiming Gao, Linda Moy

Erschienen in: Current Breast Cancer Reports | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

The role of breast MRI in patients with newly diagnosed breast cancer is controversial. Preoperative MRI is highly sensitive and accurate in assessing tumor size, extensive intraductal component (EIC), and in detection of additional sites of disease. It also has utility in assessing chest wall, nipple-areolar complex, and nodal involvement. Yet there are conflicting results in whether the use of preoperative MRI improves re-excision rate, local recurrence rate, and ultimately, survival. MRI has also been associated with overestimation of disease and increased mastectomy rates, and may contribute to treatment delay. Nevertheless, certain subgroups of patients may benefit more from preoperative MRI than others, including those with invasive lobular cancer (ILC), dense breasts, and those at elevated risk for breast cancer.
Literatur
1.
Stout NK, Nekhlyudov L, Li L, et al. Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011. JAMA Intern Med. 2014;174(1):114–21.PubMedPubMedCentralCrossRef
2.
Bassett LW, Dhaliwal SG, Eradat J, et al. National trends and practices in breast MRI. Am J Roentgenol. 2008;191(2):332–9.CrossRef
3.
Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer 1. Radiology. 2004;233(3):830–49.PubMedCrossRef
4.
Onesti JK, Mangus BE, Helmer SD, Osland JS. Breast cancer tumor size: correlation between magnetic resonance imaging and pathology measurements. Am J Surg. 2008;196(6):844–50.PubMedCrossRef
5.
Luparia A, Mariscotti G, Durando M, et al. Accuracy of tumour size assessment in the preoperative staging of breast cancer: comparison of digital mammography, tomosynthesis, ultrasound and MRI. Radiol Med. 2013;118(7):1119–36.PubMedCrossRef
6.
Jethava A, Ali S, Wakefield D, Crowell R, Sporn J, Vrendenburgh J. Diagnostic accuracy of MRI in predicting breast tumor size: comparative analysis of MRI vs histopathological assessed breast tumor size. Conn Med. 2015;79(5):261.PubMed
7.
Van Goethem M, Schelfout K, Dijckmans L, et al. MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol. 2004;14(5):809–16.PubMedCrossRef
8.
Kim WH, Chang JM, Moon H-G, et al. Comparison of the diagnostic performance of digital breast tomosynthesis and magnetic resonance imaging added to digital mammography in women with known breast cancers. Eur Radiol. 2015:1-9.
9.
Hollingsworth AB, Stough RG, O’Dell CA, Brekke CE. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg. 2008;196(3):389–97.PubMedCrossRef
10.
Mercier J, Kwiatkowski F, Abrial C, et al. The role of tomosynthesis in breast cancer staging in 75 patients. Diagn Interv Imaging. 2015;96(1):27–35.PubMedCrossRef
11.
Schnall MD, Blume J, Bluemke DA, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol. 2005;92(1):32–8.PubMedCrossRef
12.
Van Goethem M, Schelfout K, Kersschot E, et al. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Eur J Radiol. 2007;62(2):273–82.PubMedCrossRef
13.
Schouten van der Velden A, Boetes C, Bult P, Wobbes T. Magnetic resonance imaging in size assessment of invasive breast carcinoma with an extensive intraductal component. BMC Med Imaging. 2009;2009:5.CrossRef
14.
Hata T, Takahashi H, Watanabe K, et al. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J Am Coll Surg. 2004;198(2):190–7.PubMedCrossRef
15.
Lehman CD, DeMartini W, Anderson BO, Edge SB. Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Cancer Netw. 2009;7(2):193–201.
16.
Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26(19):3248–58.PubMedCrossRef
17.
Plana MN, Carreira C, Muriel A, et al. Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis. Eur Radiol. 2012;22(1):26–38.PubMedCrossRef
18.
Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. Am J Roentgenol. 2003;180(4):901–10.CrossRef
19.
Liberman L, Morris EA, Kim CM, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. Am J Roentgenol. 2003;180(2):333–41.CrossRef
20.
El Khouli RH, Jacobs MA, Macura KJ. Breast MRI for diagnosis and staging of breast cancer. Breast Cancer Screen Diagn Springer. 2015;2015:181–200.
21.
DeMartini W, Lehman C, Partridge S. Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications. Acad Radiol. 2008;15(4):408–16.PubMedCrossRef
22.
Kropcho LC, Steen ST, Chung AP, Sim MS, Kirsch DL, Giuliano AE. Preoperative breast MRI in the surgical treatment of ductal carcinoma in situ. Breast J. 2012;18(2):151–6.PubMedCrossRef
23.
Pilewskie M, Kennedy C, Shappell C, et al. Effect of MRI on the management of ductal carcinoma in situ of the breast. Ann Surg Oncol. 2013;20(5):1522–9.PubMedCrossRef
24.
van der Velden APS, Boetes C, Bult P, Wobbes T. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg. 2006;192(2):172–8.CrossRef
25.
Houssami N, Turner R, Morrow M. Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg. 2013;257(2):249–55.PubMedCrossRef
26.
Itakura K, Lessing J, Sakata T, et al. The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ. Clin Breast Cancer. 2011;11(1):33–8.PubMedPubMedCentralCrossRef
27.
28.
29.
30.
Sardanelli F, Boetes C, Borisch B, et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer. 2010;46(8):1296–316.PubMedCrossRef
31.
Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23(33):8469–76.PubMedCrossRef
32.
Rahbar H, DeMartini WB, Lee AY, Partridge SC, Peacock S, Lehman CD. Accuracy of 3T versus 1.5 T breast MRI for pre-operative assessment of extent of disease in newly diagnosed DCIS. Eur J Radiol. 2015;84(4):611–6.PubMedPubMedCentralCrossRef
33.
Brasic N, Wisner DJ, Joe BN. Breast MR imaging for extent of disease assessment in patients with newly diagnosed breast cancer. Magn Reson Imaging Clin N Am. 2013;21(3):519–32.PubMedCrossRef
34.
van der Velden APS, Schlooz-Vries MS, Boetes C, Wobbes T. Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review. Am J Surg. 2009;198(2):262–9.CrossRef
35.
Mossa-Basha M, Fundaro GM, Shah BA, Ali S, Pantelic MV. Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation 1. Radiographics. 2010;30(6):1673–87.PubMedCrossRef
36.
Harms SE. The use of breast magnetic resonance imaging in ductal carcinoma in situ. Breast J. 2005;11(6):379–81.PubMedCrossRef
37.
Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370(9586):485–92.PubMedCrossRef
38.
Lehman CD. Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2009;2010(41):150–1.CrossRef
39.
Kim DY, Moon WK, Cho N, et al. MRI of the breast for the detection and assessment of the size of ductal carcinoma in situ. Korean J Radiol. 2007;8(1):32–9.PubMedPubMedCentralCrossRef
40.
Deurloo EE, Sriram JD, Teertstra HJ, et al. MRI of the breast in patients with DCIS to exclude the presence of invasive disease. Eur Radiol. 2012;22(7):1504–11.PubMedCrossRef
41.
Goto M, Yuen S, Akazawa K, et al. The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy. Eur Radiol. 2012;22(6):1255–64.PubMedCrossRef
42.
Hollingsworth AB, Stough RG. Multicentric and contralateral invasive tumors identified with pre-op MRI in patients newly diagnosed with ductal carcinoma in situ of the breast. Breast J. 2012;18(5):420–7.PubMedCrossRef
43.
Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol. 2003;10(4):381–8.PubMedCrossRef
44.
Huang Y-T, Cheung Y-C, Lo Y-F, Ueng S-H, Kuo W-L, Chen S-C. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy. Acta Radiol. 2011;52(10):1064–8.PubMedCrossRef
45.
Morris EA, Schwartz LH, Drotman MB, et al. Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experience 1. Radiology. 2000;214(1):67–72.PubMedCrossRef
46.
Moon JY, Chang Y-W, Lee EH, Seo DY. Malignant invasion of the nipple-areolar complex of the breast: usefulness of breast MRI. Am J Roentgenol. 2013;201(2):448–55.CrossRef
47.
Sakamoto N, Tozaki M, Hoshi K, Fukuma E. Is MRI useful for the prediction of nipple involvement? Breast Cancer. 2013;20(4):316–22.PubMedCrossRef
48.
Ponzone R, Maggiorotto F, Carabalona S, et al. MRI and intraoperative pathology to predict nipple–areola complex (NAC) involvement in patients undergoing NAC-sparing mastectomy. Eur J Cancer. 2015;51(14):1882–9.PubMedCrossRef
49.
Steen ST, Chung AP, Han S-H, Vinstein AL, Yoon JL, Giuliano AE. Predicting nipple–areolar involvement using preoperative breast MRI and primary tumor characteristics. Ann Surg Oncol. 2013;20(2):633–9.PubMedCrossRef
50.
Hyun S, Kim E-K, Yoon J, Moon H, Kim M. Adding MRI to ultrasound and ultrasound-guided fine-needle aspiration reduces the false-negative rate of axillary lymph node metastasis diagnosis in breast cancer patients. Clin Radiol. 2015;70:716–22.PubMedCrossRef
51.
Luciani A, Dao TH, Lapeyre M, et al. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results. Am J Roentgenol. 2004;182(4):1059–67.CrossRef
52.
Kvistad K, Rydland J, Smethurst H-B, Lundgren S, Fjøsne H, Haraldseth O. Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol. 2000;10(9):1464–71.PubMedCrossRef
53.
Rahbar H, Conlin JL, Parsian S, et al. Suspicious axillary lymph nodes identified on clinical breast MRI in patients newly diagnosed with breast cancer: can quantitative features improve discrimination of malignant from benign? Acad Radiol. 2015;22(4):430–8.PubMedPubMedCentralCrossRef
54.
Rautiainen S, Kononen M, Sironen R, et al. Preoperative axillary staging with 3.0-T breast MRI: clinical value of diffusion imaging and apparent diffusion coefficient. PLoS One. 2015;10(3):e0122516.PubMedPubMedCentralCrossRef
55.
Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252(3):426–33.PubMed
56.
Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98(3):468–73.PubMedCrossRef
57.
Angarita FA, Acuna SA, Fonseca A, Crystal P, Escallon J. Impact of preoperative breast MRIs on timing of surgery and type of intervention in newly diagnosed breast cancer patients. Ann Surg Oncol. 2010;17(3):273–9.PubMedCrossRef
58.
Kneeshaw P, Turnbull L, Smith A, Drew P. Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. Eur J Surg Oncol. 2003;29(1):32–7.PubMedCrossRef
59.
McGhan LJ, Wasif N, Gray RJ, et al. Use of preoperative magnetic resonance imaging for invasive lobular cancer: good, better, but maybe not the best? Ann Surg Oncol. 2010;17(3):255–62.PubMedCrossRef
60.
Heil J, Bühler A, Golatta M, et al. Does a supplementary preoperative breast MRI in patients with invasive lobular breast cancer change primary and secondary surgical interventions? Ann Surg Oncol. 2011;18(8):2143–9.PubMedCrossRef
61.•
Fortune-Greeley AK, Wheeler SB, Meyer A-M, et al. Preoperative breast MRI and surgical outcomes in elderly women with invasive ductal and lobular carcinoma: a population-based study. Breast Cancer Res Treat. 2014;143(1):203–12. This population based study of patients with early stage breast cancer found that preoerative MRI reduced excision rates in patients with invasive lobular cancer without affecting final mastectomy rates. Overall, and in patients with invasive ductal histology, there was no reduction in re-excision rates and an increase in final mastectomy rates.PubMedPubMedCentralCrossRef
62.
Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209(2):180–7.PubMedPubMedCentralCrossRef
63.
Turnbull LW, Brown SR, Olivier C, et al. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess. 2010;14(1):1–182.PubMedCrossRef
64.
Peters N, Van Esser S, van den Bosch M, et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET-randomised controlled trial. Eur J Cancer. 2011;47(6):879–86.PubMedCrossRef
65.•
Gonzalez V, Sandelin K, Karlsson A, et al. Preoperative MRI of the breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study. World J Surg. 2014;38(7):1685–93. This prospective, randomized, multicneter study demostated a significant reduction in reoperation rates in patients with preoperative MRI. Conversion to mastectomy from breast conservation was also higher in those with preoperative MRI, though final mastectomy rates were not significantly different.PubMedCrossRef
66.
Chandwani S, George PA, Azu M, et al. Role of preoperative magnetic resonance imaging in the surgical management of early-stage breast cancer. Ann Surg Oncol. 2014;21(11):3473–80.PubMedPubMedCentralCrossRef
67.
Patel BK, Shah NA, Galgano SJ, et al. Does preoperative MRI workup affect mastectomy rates and/or re-excision rates in patients with newly diagnosed breast carcinoma? A retrospective review. Breast J. 2015;21(6):604–9.PubMedCrossRef
68.
Fancellu A, Turner RM, Dixon JM, Pinna A, Cottu P, Houssami N. Meta‐analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ. Br J Surg. 2015;102:883–93.PubMedCrossRef
69.
Grady I, Gorsuch‐Rafferty H, Hadley P. Preoperative staging with magnetic resonance imaging, with confirmatory biopsy, improves surgical outcomes in women with breast cancer without increasing rates of mastectomy. Breast J. 2012;18(3):214–8.PubMedCrossRef
70.
Obdeijn I-M, Tilanus-Linthorst MM, Spronk S, et al. Preoperative breast MRI can reduce the rate of tumor-positive resection margins and reoperations in patients undergoing breast-conserving surgery. Am J Roentgenol. 2013;200(2):304–10.CrossRef
71.
Sung JS, Li J, Da Costa G, et al. Preoperative breast MRI for early-stage breast cancer: effect on surgical and long-term outcomes. Am J Roentgenol. 2014;202(6):1376–82.CrossRef
72.
73.
Van Goethem M, Tjalma W, Schelfout K, Verslegers I, Biltjes I, Parizel P. Magnetic resonance imaging in breast cancer. Eur J Surg Oncol. 2006;32(9):901–10.PubMedCrossRef
74.
Marcotte-Bloch C, Balu-Maestro C, Chamorey E, et al. MRI for the size assessment of pure ductal carcinoma in situ (DCIS): a prospective study of 33 patients. Eur J Radiol. 2011;77(3):462–7.PubMedCrossRef
75.
Ko ES, Han BK, Kim RB, et al. Analysis of the effect of breast magnetic resonance imaging on the outcome in women undergoing breast conservation surgery with radiation therapy. J Surg Oncol. 2013;107(8):815–21.PubMedCrossRef
76.•
Houssami N, Turner R, Macaskill P, et al. An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence. J Clin Oncol. 2014. doi:10.​1200/​JCO.​2013.​52.​7515. This meta-analysis showed that preoperative MRI did not reduce the rates of local or distant recurrence.
77.
Pilewskie M, Olcese C, Eaton A, et al. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation. Ann Surg Oncol. 2014;21(5):1552–60.PubMedPubMedCentralCrossRef
78.
Yi A, Cho N, Yang K-S, Han W, Noh D-Y, Moon WK. Breast cancer recurrence in patients with newly diagnosed breast cancer without and with preoperative MR imaging: a matched cohort study. Radiology. 2015. doi:10.​1148/​radiol.​2015142101.
79.
Bae MS, Moon H-G, Han W, et al. Early stage triple-negative breast cancer: imaging and clinical-pathologic factors associated with recurrence. Radiology. 2015. doi:10.​1148/​radiol.​2015150089.
80.
Fischer U, Zachariae O, Baum F, von Heyden D, Funke M, Liersch T. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol. 2004;14(10):1725–31.PubMedCrossRef
81.
Boetes C, Veltman J, van Die L, Bult P, Wobbes T, Barentsz JO. The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat. 2004;86(1):31–7.PubMedCrossRef
82.
Brem RF, Ioffe M, Rapelyea JA, et al. Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging. Am J Roentgenol. 2009;192(2):379–83.CrossRef
83.
Caramella T, Chapellier C, Ettore F, Raoust I, Chamorey E, Balu-Maestro C. Value of MRI in the surgical planning of invasive lobular breast carcinoma: a prospective and a retrospective study of 57 cases: comparison with physical examination, conventional imaging, and histology. Clin Imaging. 2007;31(3):155–61.PubMedCrossRef
84.
Mann RM, Hoogeveen YL, Blickman JG, Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat. 2008;107(1):1–14.PubMedPubMedCentralCrossRef
85.
Schelfout K, Van Goethem M, Kersschot E, et al. Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol. 2004;14(7):1209–16.PubMedCrossRef
86.
Mann RM, Loo CE, Wobbes T, et al. The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2010;119(2):415–22.PubMedCrossRef
87.
De Bresser J, De Vos B, Van der Ent F, Hulsewe K. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. Eur J Surg Oncol. 2010;36(2):114–9.PubMedCrossRef
88.
Lehman CD, Blume JD, Thickman D, et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol. 2005;92(1):9–15.PubMedCrossRef
89.
Lehman CD, Isaacs C, Schnall MD, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study 1. Radiology. 2007;244(2):381–8.PubMedCrossRef
90.
Lord S, Lei W, Craft P, et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer. 2007;43(13):1905–17.PubMedCrossRef
91.
Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292(11):1317–25.PubMedCrossRef
92.
McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15(6):1159–69.CrossRef
93.
Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356(3):227–36.PubMedCrossRef
94.
Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394–404.PubMedPubMedCentralCrossRef
95.
Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. Am J Roentgenol. 2004;183(4):1149–57.CrossRef
96.
Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74(4):987–1001.PubMedCrossRef
97.
Dorn PL, Al-Hallaq HA, Haq F, et al. A prospective study of the utility of magnetic resonance imaging in determining candidacy for partial breast irradiation. Int J Radiat Oncol Biol Phys. 2013;85(3):615–22.PubMedPubMedCentralCrossRef
Metadaten
Titel
Role of Breast MRI in Patients with Newly Diagnosed Breast Cancer
verfasst von
Marissa L. Albert
Yiming Gao
Linda Moy
Publikationsdatum
13.04.2016
Verlag
Springer US
Erschienen in
Current Breast Cancer Reports / Ausgabe 2/2016
Print ISSN: 1943-4588
Elektronische ISSN: 1943-4596
DOI
https://doi.org/10.1007/s12609-016-0205-8

Weitere Artikel der Ausgabe 2/2016

Current Breast Cancer Reports 2/2016 Zur Ausgabe

Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

New Developments in Assessing Risk of Local Recurrence in Patients with Ductal Carcinoma In Situ after Lumpectomy and Breast Radiation

Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

The Optimal Approach to Post-Mastectomy and Post-Lumpectomy Breast Reconstruction

Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

Margins in Breast-Conserving Surgery for Early Breast Cancer: How Much is Good Enough?

Biomarkers (S Dawood, Section Editor)

Defining the Prognostic and Predictive Role of PIK3CA Mutations: Sifting Through the Conflicting Data

Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

Oncoplastic Breast Surgery: What, When and for Whom?

Biomarkers (S Dawood, Section Editor)

Emerging Biomarkers of the Future: Changing Clinical Practice for 2020

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Prostatakarzinom: EU initiiert neues Screeningkonzept

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Blasenkarzinom – Biomarker statt Zytologie?

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

17.04.2024 | Mammakarzinom | Nachrichten

Adjuvante Brustkrebstherapie: Doppelt hält besser
weitere anzeigen

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen